在农村继续医学教育计划中为全科医生开发和验证一门关于质子抑制剂的培训课程:试点研究
Laure Esparbes1, Emile Escourrou1, Jordan Birebent1
1Département Universitaire de Médecine Générale, Faculté de Médecine Rangueil, Université Paul Sabatier Toulouse III, 133 route de Narbonne, Toulouse, 31400, France.
BMC medical education
|October 28, 2024
概括
一个持续的医学教育计划有效地改善了农村全科医生 (GPs) 的质子抑制剂 (PPI) 处方. 这项干预措施增强了知识和实践,导致服务不足地区的患者获得更好的治疗结果.
科学领域:
- 医疗教育 医学教育
- 药理学 药理学是指药理学的学科.
- 初级保健研究研究初级保健研究
背景情况:
- 质子抑制剂 (PPI) 广泛用于胃肠道疾病,但在过度处方,副作用和药物相互作用方面存在担忧.
- 农村地区的全科医生面临着独特的挑战,包括工作量增加和资源有限,需要针对性干预以进行适当的处方.
- 促进PPI减记对于优化患者护理和减轻长期使用相关的潜在风险至关重要.
研究的目的:
- 评估持续医学教育 (CME) 计划的有效性,该计划旨在改善农村 GP 中的 PPI 处方实践.
- 评估CME计划对全科医生的知识,满意度和临床实践对PPI脱的影响.
- 通过有针对性的教育战略,解决在服务不足的农村初级保健机构中过度使用PPI的挑战.
主要方法:
- 为农村的全科医生开发了一项专注于PPI解药的CME计划,包括交互式会议和教育材料.
- 柯克帕特里克模型 (一级和二级) 用于通过课程前后问卷来评估参与者的满意度和知识获取.
- 三十三位全科医生参加了会议,收集了有关他们的医疗经验,当前做法和在PPI管理中所感知的挑战的数据.
主要成果:
- 参与者报告了高满意度 (9.1/10) 和显著的实践变化,其中92.9%的人确定了课程后不适当的PPI使用.
- 关键的实践转变包括增加了对PPI指示的重新评估 (71.4%),更大程度上需要多次咨询来停止处方 (64.3%),系统的逐步停止 (100%),并增加了辅助抗酸药的使用 (92.9%).
- 尽管承认PPI过度处方 (95.2%),但没有参与者先前就PPI不再处方进行专门的CME,这突出了该计划所解决的知识差距.
结论:
- 有针对性的CME计划有效地提高了全科医生的知识,并促进了农村环境中适当的PPI处方实践.
- 该研究表明,该计划在促进 PPI 的积极管理方面取得了成功,即便在初始治疗失败的情况下,也可以停止处方.
- 量身定制的教育干预措施对于改善药物管理和改善农村初级保健患者的结果至关重要,解决全科医生面临的具体挑战.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
360
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
360
Peptic Ulcer Disease IV: Management
74
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
74
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
328
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
328
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
407
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
407
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
Drug Dosage Regimen: Overview
3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K


